We are live on
!
Find out more
FRA
Front Row Advisors Portfolio holdings
AUM
$296M
1-Year Est. Return
34.73%
This Fund
S&P 500
This Quarter
Est. Return
+17.22%
1 Year Est. Return
+34.73%
3 Year Est. Return
+122.22%
5 Year Est. Return
+164.22%
10 Year Est. Return
–
AUM
$270M
AUM Growth
+$52.1M
(+24%)
Cap. Flow
+$22M
Cap. Flow
% of AUM
8.14%
Top 10 Holdings %
Top 10 Hldgs %
40.76%
Holding
941
New
464
Increased
200
Reduced
32
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.34M |
| 2 |
ExxonMobil
XOM
|
+$1.31M |
| 3 |
Chevron
CVX
|
+$1.25M |
| 4 |
Eli Lilly
LLY
|
+$685K |
| 5 |
JPMorgan Chase
JPM
|
+$684K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.18M |
| 2 |
NVIDIA
NVDA
|
+$618K |
| 3 |
Broadcom
AVGO
|
+$138K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$113K |
| 5 |
Apple
AAPL
|
+$105K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.15% |
| 2 | Healthcare | 9.98% |
| 3 | Consumer Staples | 7.57% |
| 4 | Financials | 6.32% |
| 5 | Industrials | 6.02% |
Similar funds
SM
RHP
MSWM
RLIM
JCM
CA
KNFPWM
NRC
Front Row Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Front Row Advisors held 941 positions worth $270M, up 24% from $218M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Front Row Advisors deployed $22M of net new capital in Q1 2024, opening 464 new positions and adding to 200 existing holdings. Its largest new stake was Vanguard Information Technology ETF: 8,008 shares worth $525K.
By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was Pfizer, an estimated $1.18M trimmed.
- Front Row Advisors's largest Q1 2024 buy was Vanguard Information Technology ETF: 8,008 shares worth $525K.
- Front Row Advisors added most to Berkshire Hathaway Class B in Q1 2024, an estimated $1.34M increase.
- Front Row Advisors's biggest Q1 2024 reduction was Pfizer, cutting an estimated $1.18M.
- Front Row Advisors fully exited Atlantica Sustainable Infrastructure plc Ordinary Shares in Q1 2024, selling an estimated $16.2K.
- Front Row Advisors's ten largest holdings make up 41% of its $270M portfolio in Q1 2024.
- Front Row Advisors opened 464 new positions and closed 8 in Q1 2024.
- Front Row Advisors's portfolio value rose 24% quarter-over-quarter to $270M.
Based on Front Row Advisors's 13F filing for Q1 2024, filed 14 May 2024.